Patent · US Active

Aptamers inhibiting the enzymatic activity of the MMP-9 protein

US9902961B2 · kind B2 · utility

6Cited by

1References

14Claims

0Family size

Assignees

LVMH RECHERCHE · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Eric Dausse · Bordeaux, FR
Jean-Jacques Toulme · Lormont, FR
Jean Hubert Cauchard · Orléans, FR
Robin Kurfurst · Val-de-Reuil, FR
Sylvianne Schnebert · Olivet, FR

Key dates

Filing date	Dec 30, 2014
Grant date	Feb 27, 2018
Priority date	—
Expiry date	Dec 30, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/51
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to an aptamer that has a G-quadruplex structure and is able to inhibit the enzymatic activity of the MMP-9 protein, as well as to the dermatological and cosmetic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.